A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to CRC
Related studies linked through entity extraction aliases.
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Microbiome in Colorectal Cancer Onset and Progression
- Status
- TERMINATED
- Phase
- N/A
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
- Status
- UNKNOWN
- Phase
- N/A
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)
- Status
- UNKNOWN
- Phase
- PHASE2
HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Status
- RECRUITING
- Phase
- N/A
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate D-1553 in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation
- Status
- TERMINATED
- Phase
- NA
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2